Characteristics of Long-Term and Short-Term Survivors of Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: Results From the International mRCC Database Consortium

Baseline prognostic criteria and absence of PD after first and second-line targeted therapy may characterize long-term survival.